RE:RE:RE:Trogarzo 30 sec i.v. push over two weeksWith the last patient in the IM trial expected in November 2022, you are probably looking at at least a year before IM gets approved. But IM will not likely move the needle much for sales either asit is still an injection versus a pill, not to mention a small THTX sales force up against a much larger company in Viiv.
Trogarzo had a good chance to make hay before the competition arrived but failed to do so. I suspect these new methods of administration may be more intended to slow attrition of sales than to add meaningfully to them, but I hope I am wrong.
Biobob wrote: How long will they market IV before IM gets the nod... I mean they do have to package and market IV version.... only to switch to IM like in a 2-3 years maybe....